News

Mast Group are pleased to announce that they are PEPPOL ready and can now accept electronic orders to  provide you with an electronic Invoice.

Mast are proud to be one of the sponsors of the British Society for Microbial Technology (BSMT) virtual conference on ‘Covid-19, The Infection Challenging the World’ 11th May - 14th May 2021.

Effective immediately Mast Group Ltd will no longer be accepting orders via our Fax number.

Toxoplasma gondii is a protozoan parasite, its primary host being the Felidae family (cats), but is a parasite that can infect all homeotherms. 

Mast is a responsible company that believes in taking a proportionate view on the likelihood of a number of events that may be outside of its control.

During ‘World Antimicrobial Awareness Week’ Mast unite to preserve antimicrobials by continuing to support Antibiotic stewardship, in providing and continually updating its range of in vitro diagnostic (IVD) Antimicrobial Resistance (AMR) products to reduce time to appropriate treatment decision and allow for a more targeted use of therapy against infection.

MAST^®ALEX-MRSA (RST501); for the detection of penicillin binding protein 2’ (PBP2’) and confirmation of Methicillin resistant Staphylococcus aureus (MRSA)

COVID-19 Update

Mast is pleased to announce the launch of NEW additions to the MASTDISCS^® AST range for EUCAST and CLSI methodology:

Mast Group Ltd. are pleased to announce the expansion of their molecular product portfolio with the launch of the New MAST ISOPLEX^® CRE-ART  kit for the rapid molecular detection of carbapenemase producing organisms (CPOs).